Aptose Biosciences Inc.
APS.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.04M | -5.54M | -1.59M | -6.95M | -7.25M |
| Total Depreciation and Amortization | 102.00K | 99.00K | 97.00K | 96.00K | 102.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 206.00K | 482.00K | -599.00K | 2.00K | 283.00K |
| Change in Net Operating Assets | 792.00K | 2.17M | -5.97M | -3.52M | 1.09M |
| Cash from Operations | -5.94M | -2.80M | -8.06M | -10.38M | -5.78M |
| Capital Expenditure | -- | -- | -5.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 5.00K | -- | 17.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 1.99M |
| Cash from Investing | -- | -- | 0.00 | -- | 2.01M |
| Total Debt Issued | 2.60M | -- | 10.00M | -- | -- |
| Total Debt Repaid | -100.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 829.00K | -- | 10.01M | 4.93M |
| Repurchase of Common Stock | -- | -- | -3.35M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 156.00K | -- | -177.00K |
| Cash from Financing | 2.50M | 829.00K | 6.81M | 10.01M | 4.75M |
| Foreign Exchange rate Adjustments | -2.00K | 2.00K | -- | -- | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.45M | -1.96M | -1.26M | -368.00K | 984.00K |